Literature DB >> 9194860

Stromal and vascular invasion in an human in vitro bladder cancer model.

C Booth1, P Harnden, L K Trejdosiewicz, S Scriven, P J Selby, J Southgate.   

Abstract

In transitional cell carcinoma (TCC) of the urinary bladder, disease spread may occur through local invasion of the bladder wall and/or via hematogenous dissemination. Although the metastatic phenotype is well studied, little is known about the mechanisms that determine and regulate secondary dispersion via stromal and vascular routes. The aim of this study was to develop an in vitro system to study TCC invasion using normal human urinary tract stroma in organ culture. Human de-epithelialized urinary tract stromas were seeded with established human TCC cell lines (RT4, RT112, and EJ) and maintained in organ culture at an air-liquid interface for up to 8 weeks. The composite tissues were analyzed immunohistochemically using antibodies to a proliferation-associated antigen, cell adhesion molecules, extracellular matrix components, and cytokeratin isotypes. The phenotype of TCC cell lines maintained as monolayer cultures were compared with the composite tissues to assess the regulatory effects of the stroma. On a normal urothelial stroma, the TCC cell lines proliferated and underwent a degree of differentiation related to the grade of the original tumor. RT4 cells formed a stratified epithelium with low proliferation, some characteristics of urothelial differentiation, and no evidence of stromal invasion over the 8-week culture period. RT12 cells formed a stratified epithelium with limited differentiation and by 2 weeks showed intravasation of the subepithelial capillary bed. Anaplastic EJ cells did not stratify but diffusely invaded the stromal matrix and the superficial vasculature. In conclusion, the urothelial stroma can support cytodifferentiation in vitro and influence the behavior of malignant TCC cells. The model has application for determining genetic and epigenetic factors that influence whether a tumor progresses by local and/or hematogenous spread. Furthermore, it may offer a useful approach in evaluating prognostic and diagnostic markers and strategies for preventing invasion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194860

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  15 in total

1.  Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast.

Authors:  T Hasebe; S Sasaki; S Imoto; A Ochiai
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage.

Authors:  Peter C Rubenwolf; Wolfgang Otto; Stefan Denzinger; Ferdinand Hofstädter; Wolf Wieland; Nikolaos T Georgopoulos
Journal:  World J Urol       Date:  2014-08       Impact factor: 4.226

3.  Bladder organoids: a step towards personalised cancer therapy?

Authors:  Sreemoti Banerjee; Jennifer Southgate
Journal:  Transl Androl Urol       Date:  2019-07

4.  Uroplakin gene expression by normal and neoplastic human urothelium.

Authors:  E D Lobban; B A Smith; G D Hall; P Harnden; P Roberts; P J Selby; L K Trejdosiewicz; J Southgate
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

5.  Proliferative activities of tumor stromal cells play important roles in tumor thickness and progression of T3 ulcerative-type colorectal cancer.

Authors:  Takahiro Hasebe; Satoshi Sasaki; Masanori Sugitoh; Masato Ono; Norio Saitoh; Atsushi Ochiai
Journal:  Virchows Arch       Date:  2003-05-13       Impact factor: 4.064

6.  Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients.

Authors:  A A Memon; B S Sorensen; P Melgard; L Fokdal; T Thykjaer; E Nexo
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

7.  hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours.

Authors:  J E Nutt; P A Foster; J K Mellon; J Lunec
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

8.  Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion.

Authors:  C Fujiyama; A Jones; S Fuggle; R Bicknell; D Cranston; A L Harris
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

9.  A new and reliable culture system for superficial low-grade urothelial carcinoma of the bladder.

Authors:  Hans-Helge Seifert; Andrea Meyer; Marcus V Cronauer; Jiri Hatina; Mirko Müller; Harald Rieder; Michele J Hoffmann; Rolf Ackermann; Wolfgang A Schulz
Journal:  World J Urol       Date:  2007-04-18       Impact factor: 3.661

10.  Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2.

Authors:  J E Nutt; H P Lazarowicz; J K Mellon; J Lunec
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.